Recombinant human thrombopoietin: all 45 studies that test it
Page 1 of 1. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.
- rhTPO + CsA vs CsA in the Treatment of LR-MDS With ThrombocytopeniaNot yet recruitingNCT07653581Phase 3
- A Study of Hetrombopag Combined With rhTPO in the Treatment of Cancer Therapy-induced Thrombocytopenia (CTIT) in Solid Tumor Patients.Not yet recruitingNCT07334093Phase 2
- Efficacy and Safety of rhTPO in Combination With Cyclosporine Versus Cyclosporine Alone in the Treatment of TD-NSAANot yet recruitingNCT06525948Phase 4
- Efficacy and Safety of rhTPO's Prophylactic Treatment of CTIT in Patients With High Risk of Cardiac InjuryRecruitingNCT05411705Phase 4
- Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen in Acute Myeloid Leukemia: Study Protocol for a Randomized Controlled TrialRecruitingNCT05382390Phase 3
- Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen for Elderly Patients With Acute Myeloid Leukemia: A Phase II Single-Arm Multicenter StudyRecruitingNCT05258799Not applicable
- The Effect of REcombinant Human Thrombopoietin (rhTPO) on Sepsis Patients With aCUte Severe thrombocytopEniaRecruitingNCT02707497Phase 2/3
- Prospective Study of Patients With Thrombocytopenia Following HSCTCompletedNCT02487563Phase 3Results posted
- A Prospective Study of the Early Treatment of Recombinant Human Thrombopoietin for Chemoradiation Induced Thrombocytopenia in Cervical Squamous Cell Carcinoma PatientCompletedNCT07649395Not applicable
- Phase I Study to Evaluate rhTPO in Healthy Caucasian VolunteersCompletedNCT06630494Phase 1
- The Effect of Prophylactic TPO Combined with BMS-IMRT to Esophageal Cancer PatientsCompletedNCT05944809Phase 2
- IVIg Plus Low Dose rhTPO for ITP in PregnancyStatus unknownNCT05634824Phase 2
- A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP PtsCompletedNCT05583838Phase 4
- A Clinical Study of Herombopag in Tumors-associated ThrombocytopeniaStatus unknownNCT05350956Phase 2
- Herombopag + rhTPO in Severe Immune ThrombocytopeniaStatus unknownNCT05328804Phase 3
- Effects of Recombinant Human Thrombopoietin on Platelet Levels in ICU PatientsStatus unknownNCT05217719Phase 4
- A Phase Ib Clinical Study for rhTPO in the Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseStatus unknownNCT05193201Phase 1
- Fixed Low-dose Eltrombopag and rhTPO for Immune Thrombocytopenia (FLOWER)Status unknownNCT04518878Phase 1
- Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19)Status unknownNCT04516837Phase 2
- A Randomized Trial of rhTPO Versus Placebo for Low/Intermediate-1 Risk MDS With ThrombocytopeniaStatus unknownNCT04324060Phase 2/3
- D-CTAG in the Treatment of Newly Diagnosed Acute Myeloid Leukemia in Elderly PatientsStatus unknownNCT04168138Not applicable
- Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With ThrombocytopeniaStatus unknownNCT03823079Phase 2
- Efficacy and Safety of rhTPO and Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP)Status unknownNCT03771378Phase 4
- The Tolerability，Safety，PK/PD Study of rhTPO in the Patients With Liver Function ImpairmentStatus unknownNCT03673215Early Phase 1
- High-dose Use of rhTPO in CIT PatientsStatus unknownNCT03633019Phase 4
- Recombinant Human Thrombopoietin(rhTPO) in Pregnancy With Immune ThrombocytopeniaStatus unknownNCT03492515Phase 3
- Recombinant Human Thrombopoietin for Mobilization of Peripheral Blood Progenitor Cells for Autologous TransplantationStatus unknownNCT03014102Phase 1/2
- Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic AnemiaStatus unknownNCT02857530Phase 2
- Comparing Intermediate-dose CTX+ G-CSF Plus or Not rhTPO for PB CD34+ Cells Mobilization in MM PatientsStatus unknownNCT02572596Not applicable
- A Multicenter Study on Recombinant Human Thrombopoietin in Management of ITP in PregnancyCompletedNCT02391272Phase 3
- Recombinant Human Thrombopoietin (rhTPO) in Management of Immune Thrombocytopenia (ITP) in PregnancyStatus unknownNCT02270801Phase 3
- Efficacy and Safety of rhTPO for the Treatment of Thrombocytopenia After Chemotherapy in AML PatientsCompletedNCT02267993Phase 4
- Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic LeukemiaStatus unknownNCT02244658Phase 3
- A Multicenter Investigation of Recombinant Human Thrombopoietin (rhTPO) Combining Cyclosporin A Versus Cyclosporin A in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP）WithdrawnNCT02203422Phase 3
- An Investigation of rhTPO With Different Frequencies in the Management of ITPCompletedNCT02139501Phase 3
- Efficacy and Safety Study of Maintenance Treatment With rhTPO in Thrombocytopenic Subjects With ITPStatus unknownNCT01805648Phase 3
- Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)WithdrawnNCT01734057Phase 3
- rhTPO Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of ITPCompletedNCT01734044Phase 3
- rhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITPCompletedNCT01525836Phase 3
- Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP)CompletedNCT01506414Phase 3
- Efficacy and Safety of rHuTPO on Platelet Engraftment After Allo-HSCTStatus unknownNCT01379391Phase 4
- Clinical Trial on the Prevention of Thrombocytopenia After First-line ChemotherapyTerminatedNCT01319669Phase 2/3
- Trial of Primary Prophylaxis With rhTPO Administered to Patients With High Risk Sarcoma Receiving Intensive ChemotherapyCompletedNCT00283582Phase 3
- Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide ChemotherapyCompletedNCT00187109Phase 1/2
- Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid TumorsCompletedNCT00003597Phase 1